Michael Bonham

2.9k total citations · 1 hit paper
16 papers, 2.0k citations indexed

About

Michael Bonham is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Michael Bonham has authored 16 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Michael Bonham's work include Prostate Cancer Treatment and Research (6 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Hormonal and reproductive studies (2 papers). Michael Bonham is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Hormonal and reproductive studies (2 papers). Michael Bonham collaborates with scholars based in United States, South Africa and Ireland. Michael Bonham's co-authors include Peter S. Nelson, Hugh Arnold, Pingda Ren, Davide Ruggero, Matthew R. Janes, Jonathan S. Weissman, Nicholas T. Ingolia, Andrew C. Hsieh, Morris E. Feldman and Shunyou Wang and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Michael Bonham

16 papers receiving 2.0k citations

Hit Papers

The translational landscape of mTOR signalling steers can... 2012 2026 2016 2021 2012 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Bonham United States 12 1.3k 534 324 307 197 16 2.0k
Xuesong Ouyang United States 18 1.3k 1.0× 508 1.0× 333 1.0× 419 1.4× 204 1.0× 28 1.8k
Vassiliki Tzelepi Greece 23 733 0.5× 676 1.3× 387 1.2× 417 1.4× 162 0.8× 73 1.7k
Zheng Liu China 25 983 0.7× 238 0.4× 448 1.4× 423 1.4× 158 0.8× 75 1.6k
Michele D. Vos United States 27 2.4k 1.8× 281 0.5× 472 1.5× 549 1.8× 246 1.2× 43 3.1k
Yunqian Pan United States 26 1.6k 1.2× 491 0.9× 559 1.7× 457 1.5× 120 0.6× 40 2.0k
Sreenivasa R. Chinni United States 26 1.0k 0.8× 389 0.7× 464 1.4× 809 2.6× 160 0.8× 42 2.1k
Ayesha N. Shajahan‐Haq United States 31 1.6k 1.2× 321 0.6× 529 1.6× 565 1.8× 225 1.1× 70 2.9k
Wendy J. Huss United States 22 981 0.7× 664 1.2× 497 1.5× 711 2.3× 172 0.9× 40 1.8k
Xiaoxiao Sun China 24 1.2k 0.9× 219 0.4× 317 1.0× 408 1.3× 140 0.7× 71 2.1k
Shanshan Bai China 20 1.3k 1.0× 716 1.3× 693 2.1× 480 1.6× 134 0.7× 51 2.1k

Countries citing papers authored by Michael Bonham

Since Specialization
Citations

This map shows the geographic impact of Michael Bonham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Bonham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Bonham more than expected).

Fields of papers citing papers by Michael Bonham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Bonham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Bonham. The network helps show where Michael Bonham may publish in the future.

Co-authorship network of co-authors of Michael Bonham

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Bonham. A scholar is included among the top collaborators of Michael Bonham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Bonham. Michael Bonham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Resnick, Matthew J., Margarita Lopatin, Neal D. Shore, et al.. (2016). Abstract 14: Analysis of tumor DNA in urine as a highly sensitive liquid biopsy for patients with non-muscle invasive bladder cancer (NMIBC). Clinical Cancer Research. 22(1_Supplement). 14–14. 1 indexed citations
3.
Escudier, Bernard, Serge Koscielny, Margarita Lopatin, et al.. (2014). Validation of a 16-gene signature for prediction of recurrence after nephrectomy in stage I-III clear cell renal cell carcinoma (ccRCC).. Journal of Clinical Oncology. 32(15_suppl). 4502–4502. 4 indexed citations
4.
Glass, Allison S., Sima P. Porten, Michael Bonham, et al.. (2013). Active surveillance: Does serial prostate biopsy increase histological inflammation?. Prostate Cancer and Prostatic Diseases. 16(2). 165–169. 14 indexed citations
5.
Hsieh, Andrew C., Yi Liu, Nicholas T. Ingolia, et al.. (2012). The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature. 485(7396). 55–61. 978 indexed citations breakdown →
6.
MacKenzie, John D., Melissa Shive, Laurence S. Baskin, Catherine R. Harris, & Michael Bonham. (2012). Ureteral fibroepithelial polyp causing urinary obstruction. Journal of Radiology Case Reports. 6(7). 23–8. 7 indexed citations
7.
McKenney, Jesse K., Jeff Simko, Michael Bonham, et al.. (2011). The Potential Impact of Reproducibility of Gleason Grading in Men With Early Stage Prostate Cancer Managed by Active Surveillance: A Multi-Institutional Study. The Journal of Urology. 186(2). 465–469. 84 indexed citations
8.
Washington, Samuel L., Michael Bonham, Jared M. Whitson, Janet E. Cowan, & Peter R. Carroll. (2011). Transrectal ultrasonography‐guided biopsy does not reliably identify dominant cancer location in men with low‐risk prostate cancer. British Journal of Urology. 110(1). 50–55. 38 indexed citations
9.
Bonham, Michael & Steven P. Miller. (2009). Clinical Comparison of 99th Percentile and 10% Coefficient of Variation Cutoff Values for Four Commercially Available Troponin I Assays. Laboratory Medicine. 40(8). 470–473. 5 indexed citations
10.
Montgomery, Bruce, Michael Bonham, Peter S. Nelson, et al.. (2005). Estrogen effects on tubulin expression and taxane mediated cytotoxicity in prostate cancer cells. The Prostate. 65(2). 141–150. 27 indexed citations
11.
Bonham, Michael, Jeff Posakony, Ilsa M. Coleman, et al.. (2005). Characterization of Chemical Constituents inScutellaria baicalensiswith Antiandrogenic and Growth-Inhibitory Activities toward Prostate Carcinoma. Clinical Cancer Research. 11(10). 3905–3914. 111 indexed citations
12.
Chipuk, Jerry E., Nicole J. Pultz, Joan S. Jorgensen, et al.. (2002). The Androgen Receptor Represses Transforming Growth Factor-β Signaling through Interaction with Smad3. Journal of Biological Chemistry. 277(2). 1240–1248. 159 indexed citations
13.
Bonham, Michael. (2002). Effects of the Herbal Extract PC-SPES on Microtubule Dynamics and Paclitaxel-Mediated Prostate Tumor Growth Inhibition. JNCI Journal of the National Cancer Institute. 94(21). 1641–1647. 20 indexed citations
14.
Nelson, Peter S., Nigel Clegg, Hugh Arnold, et al.. (2002). The program of androgen-responsive genes in neoplastic prostate epithelium. Proceedings of the National Academy of Sciences. 99(18). 11890–11895. 368 indexed citations
15.
Bonham, Michael, Hugh Arnold, Bruce Montgomery, & Peter S. Nelson. (2002). Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma.. PubMed. 62(14). 3920–4. 73 indexed citations
16.
Bonham, Michael & David Danielpour. (1996). Improved Purification and Yields of RNA by RNeasy®. BioTechniques. 21(1). 57–60. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026